Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    • Part of brands: |
    InternationalInternational
    • Country/Region
      • Part of brands: |
      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      Genomics Precision Diagnostic > Neurology Precision Panel > Aicardi-Goutieres Syndrome Precision Panel

      Aicardi-Goutieres Syndrome  Precision Panel

      Aicardi-Goutieres Syndrome is a rare genetic neurological disorder with variable clinical manifestations including infantile spasms-in-flexion, total or partial agenesis of the corpus callosum, and variable ocular abnormalities. It usually manifests as early-onset encephalopathy resulting in severe intellectual and physical disability. 
      Overview
      Indication
      Clinical Utility
      Genes & Diseases
      Methodology
      References

      Overview

      • Aicardi-Goutieres Syndrome is a rare genetic neurological disorder with variable clinical manifestations including infantile spasms-in-flexion, total or partial agenesis of the corpus callosum, and variable ocular abnormalities. It usually manifests as early-onset encephalopathy resulting in severe intellectual and physical disability. Genetic diagnosis is crucial due to the overlapping phenotypic features with sequelae of congenital infection and systemic lupus erythematosus (SLE). Given the phenotypic heterogeneity and diagnostic difficulties associated with young children, Aicardi-Goutieres syndrome may be a more frequent cause of mental retardation and seizure in girls than previously thought. Complications of this syndrome include severe mental retardation, intractable epilepsy and pulmonary complications. It is typically inherited in an autosomal recessive pattern. 

      • The Igenomix Aicardi-Goutieres Precision Panel can serve as an accurate and directed diagnostic tool as well as a differential diagnosis for early-onset encephalopathy ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved, and their high or intermediate penetrance.

        . 

      Indication

      • The Igenomix Aicardi-Goutieres Syndrome Precision Panel is indicated in patients with a clinical suspicion or diagnosis with or without the following manifestations: 
        • Seizures 
        • Ocular abnormalities 
        • Global developmental delay 
        • Inability to walk due to spastic hemiplegia 
        • Early presentation of malignancies such as soft tissue carcinoma, hepatoblastoma and angiosarcoma 
        • Unusually small head 
        • Hand deformities 
        • Gastrointestinal difficulties: diarrhea, constipation, difficulty eating etc 

      Clinical Utility

      The clinical utility of this panel is: 

      • The genetic and molecular diagnosis for an accurate clinical diagnosis of a symptomatic patient.    
      • Early initiation of treatment with a multidisciplinary team in the form of medical care of seizures, physical medicine and rehabilitation, prevention of pulmonary complications and early surveillance for neoplasms. Surgical care is indicated for refractory intractable epilepsy. 
      • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
      • Improve correlation of genotype and phenotype to increase diagnostic accuracy.

      Genes & Diseases

      Methodology

      References

      See scientific referrals

      Al Mutairi, F., Alfadhel, M., Nashabat, M., El-Hattab, A. W., Ben-Omran, T., Hertecant, J., Eyaid, W., Ali, R., Alasmari, A., Kara, M., Al-Twaijri, W., Filimban, R., Alshenqiti, A., Al-Owain, M., Faqeih, E., & Alkuraya, F. S. (2018). Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients. Pediatric neurology, 78, 35–40. https://doi.org/10.1016/j.pediatrneurol.2017.09.002 

      Rice, G., Patrick, T., Parmar, R., Taylor, C. F., Aeby, A., Aicardi, J., Artuch, R., Montalto, S. A., Bacino, C. A., Barroso, B., Baxter, P., Benko, W. S., Bergmann, C., Bertini, E., Biancheri, R., Blair, E. M., Blau, N., Bonthron, D. T., Briggs, T., Brueton, L. A., … Crow, Y. J. (2007). Clinical and molecular phenotype of Aicardi-Goutieres syndrome. American journal of human genetics, 81(4), 713–725. https://doi.org/10.1086/521373 

      Crow, Y. J. (2005). Aicardi-Goutières Syndrome. In M. P. Adam (Eds.) et. al., GeneReviews®. University of Washington, Seattle. 

      Crow Y. J. (2013). Aicardi-Goutières syndrome. Handbook of clinical neurology, 113, 1629–1635. https://doi.org/10.1016/B978-0-444-59565-2.00031-9 

      Kroner, B., Preiss, L., Ardini, M., & Gaillard, W. (2008). New Incidence, Prevalence, and Survival of Aicardi Syndrome From 408 Cases. Journal Of Child Neurology, 23(5), 531-535. doi: 10.1177/0883073807309782 

      Prontera, P., Bartocci, A., Ottaviani, V., Isidori, I., Rogaia, D., & Ardisia, C. et al. (2013). Aicardi Syndrome Associated with Autosomal Genomic Imbalance: Coincidence or Evidence for Autosomal Inheritance with Sex-Limited Expression?. Molecular Syndromology, 4(4), 197-202. doi: 10.1159/000350040 

      Sutton, V. R., & Van den Veyver, I. B. (2006). Aicardi Syndrome. In M. P. Adam (Eds.) et. al., GeneReviews®. University of Washington, Seattle. 

      descargar

      Detail description

      Download

      Request Information


      WE GUIDE YOU

      Fertility
      Inherited diseases prevention
      Healthy pregnancy

      To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

      OUR SERVICES

      Genetic solutions
      For patients
      How to send a sample?
      User manual

      ABOUT US

      About Igenomix
      Contact
      Quality
      Complaints
      Work with us

      FOLLOW IGENOMIX

        + 96 390 53 10
        Write us
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Europe
      • France
      • Germany
      • India
      • Italy
      • Japan
      • Korea
      • Mexico
      • Perú
      • Russia
      • Spain
      • Taiwan
      • The Middle East
      • Turkey
      • United Kingdom
      • United States
      • Vietnam
      Country/Region

      [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

      Request Information

















      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      • Country/Region
      • +34 96 390 53 10
      • Clinic Portal
      • Request Information

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in settings.

      International
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      3rd Party Cookies

      This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

      Keeping this cookie enabled helps us to improve our website.

      Please enable Strictly Necessary Cookies first so that we can save your preferences!

      Cookie Policy

      More information about our Cookie Policy